Search results
Results from the WOW.Com Content Network
SRX246, also known as API-246, is a small-molecule, centrally-active, highly-selective vasopressin V 1A receptor antagonist which is under investigation by Azevan Pharmaceuticals for the treatment of affective and anger disorders.
Intermittent explosive disorder (IED), or episodic dyscontrol syndrome (EDS), is a mental and behavioral disorder characterized by explosive outbursts of anger or violence, often to the point of rage, that are disproportionate to the situation at hand (e.g., impulsive shouting, screaming, or excessive reprimanding triggered by relatively inconsequential events).
This is a list of investigational aggression drugs, or drugs that are currently under development for clinical use in the treatment of aggression but are not yet approved. Drugs used to treat aggression may also be known as "serenics". [1]
NIH spent $35 billion in fiscal year 2023 on 50,000 grants to 300,000 researchers at more than 2,500 medical school or research institutions with $26 billion going to direct research costs and $9 ...
[152] [153] Potti's misconduct resulted in the suspension of three clinical trials based on his research and a lawsuit filed against Duke by patients enrolled in those studies. [154] As of 2021 Potti has had 11 of their research publications retracted, and one other paper has received an expression of concern.
The research began with the selection of 22 subjects from a veterans' orphanage in Iowa. None were told the intent of the research, and they believed that they were to receive speech therapy. The study was trying to induce stuttering in healthy children. The experiment became national news in the San Jose Mercury News in 2001, and a book was ...
A defense psychiatrist testified to diagnosing Smith with intermittent explosive disorder. However, the prosecution's expert said the disorder was rarely seen at Smith's age. [5] He was diagnosed with attention deficit hyperactivity disorder instead. [6] He was also diagnosed with depression. [7]
A groundbreaking $418 million settlement announced Friday by the powerful National Association of Realtors is set to usher in the most sweeping reforms the American real estate market has seen in ...